primaryid string | caseid string | caseversion string | i_f_code string | event_dt string | mfr_dt string | init_fda_dt string | fda_dt string | rept_cod string | auth_num string | mfr_num string | mfr_sndr string | lit_ref string | age string | age_cod string | age_grp string | sex string | e_sub string | wt string | wt_cod string | rept_dt string | to_mfr string | occp_cod string | reporter_country string | occr_country string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
228582971 | 22858297 | 1 | I | null | 20230823 | 20230824 | 20230824 | PER | null | US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-257073 | BOEHRINGER INGELHEIM | null | null | null | null | M | Y | null | null | 20230824 | null | CN | US | US |
228582981 | 22858298 | 1 | I | 20220624 | 20230809 | 20230824 | 20230824 | EXP | null | US-ROCHE-3392586 | ROCHE | null | 66 | YR | null | F | Y | 64 | KG | 20230824 | null | MD | US | null |
228582991 | 22858299 | 1 | I | 20230731 | 20230821 | 20230824 | 20230824 | EXP | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118561 | BRISTOL MYERS SQUIBB | null | 77 | YR | E | F | Y | null | null | 20230824 | null | CN | US | US |
228583001 | 22858300 | 1 | I | 20230728 | 20230822 | 20230824 | 20230824 | EXP | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118854 | BRISTOL MYERS SQUIBB | null | 81 | YR | E | F | Y | null | null | 20230824 | null | CN | US | US |
228583011 | 22858301 | 1 | I | null | 20230620 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017974 | SANDOZ | null | null | null | null | M | Y | 111.57 | KG | 20230824 | null | HP | US | US |
228583022 | 22858302 | 2 | F | 20230809 | 20230821 | 20230824 | 20230829 | PER | null | US-AMGEN-USASP2023148624 | AMGEN | null | 65 | YR | E | F | Y | null | null | 20230829 | null | CN | US | US |
228583031 | 22858303 | 1 | I | 20230401 | 20230822 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118623 | BRISTOL MYERS SQUIBB | null | 82 | YR | E | M | Y | null | null | 20230824 | null | CN | US | US |
228583041 | 22858304 | 1 | I | null | 20230505 | 20230824 | 20230824 | EXP | null | US-ENDO PHARMACEUTICALS INC-2023-001937 | ENDO | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228583051 | 22858305 | 1 | I | 20230813 | 20230816 | 20230824 | 20230824 | EXP | null | EG-EMD Serono-2023468715 | EMD SERONO INC | null | 23 | YR | A | F | Y | null | null | 20230824 | null | CN | EG | EG |
228583061 | 22858306 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | IT-BRISTOL-MYERS SQUIBB COMPANY-2023-118132 | BRISTOL MYERS SQUIBB | Mioso G, Gnesotto L, Russo I, Piaserico S, Alaibac M. Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma. Journal of Dermatological Treatment. 2023 Feb 23;34(1):1-2. doi:10.1080/09546634.2023.2182619. | 54 | YR | A | M | Y | null | null | 20230824 | null | HP | IT | IT |
228583071 | 22858307 | 1 | I | null | 20230731 | 20230824 | 20230824 | 30DAY | null | US-002147023-NVSC2023US041843 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228583081 | 22858308 | 1 | I | 20221101 | 20230731 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017862 | SANDOZ | null | 62 | YR | null | M | Y | null | null | 20230824 | null | CN | US | US |
228583091 | 22858309 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | NL-UCBSA-2023016605 | UCB | null | null | null | null | F | Y | 77.551 | KG | 20230824 | null | HP | NL | NL |
228583101 | 22858310 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118869 | BRISTOL MYERS SQUIBB | null | 84 | YR | E | F | Y | null | null | 20230824 | null | CN | US | US |
228583111 | 22858311 | 1 | I | 20230101 | 20230822 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023149854 | AMGEN | null | null | null | null | F | Y | null | null | 20230823 | null | CN | US | US |
228583121 | 22858312 | 1 | I | null | 20230731 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017836 | SANDOZ | null | null | null | null | F | Y | 76.19 | KG | 20230824 | null | HP | US | US |
228583131 | 22858313 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | IT-NOVITIUMPHARMA-2023ITNVP01392 | NOVITIUM PHARMA | Elia Balestra.Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy.Pediatr-Nephrol.26-JUL-2023;NA:1-5 | 13 | YR | C | F | Y | 51 | KG | 20230824 | null | HP | IT | IT |
228583141 | 22858314 | 1 | I | null | 20230731 | 20230824 | 20230824 | EXP | null | US-002147023-NVSC2023US139567 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | MD | US | US |
228583151 | 22858315 | 1 | I | 20230501 | 20230818 | 20230824 | 20230824 | EXP | null | NVSC2023CN182814 | NOVARTIS | null | 45 | YR | null | F | Y | null | null | 20230824 | null | CN | CN | CN |
228583171 | 22858317 | 1 | I | 20050101 | 20230508 | 20230824 | 20230824 | EXP | null | US-ENDO PHARMACEUTICALS INC-2023-001956 | ENDO | null | 6 | DEC | null | M | Y | null | null | 20230824 | null | CN | US | US |
228583181 | 22858318 | 1 | I | null | 20230731 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017960 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | MD | US | US |
228583191 | 22858319 | 1 | I | null | 20230615 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017959 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | HP | US | US |
228583201 | 22858320 | 1 | I | null | 20230731 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017949 | SANDOZ | null | null | null | null | F | Y | 117.91 | KG | 20230824 | null | MD | US | US |
228583211 | 22858321 | 1 | I | null | 20230821 | 20230824 | 20230824 | EXP | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118680 | BRISTOL MYERS SQUIBB | null | 91 | YR | E | F | Y | null | null | 20230824 | null | CN | US | US |
228583231 | 22858323 | 1 | I | null | 20230817 | 20230824 | 20230824 | EXP | GB-MHRA-MED-202308151735259180-DSGTY | GB-ESPERIONTHERAPEUTICS-2023GBR00911 | ESPERION THERAPEUTICS | null | 53 | YR | null | M | Y | 69 | KG | 20230824 | null | PH | GB | GB |
228583241 | 22858324 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | US-NOVITIUMPHARMA-2023USNVP01393 | NOVITIUM PHARMA | Anwar Khedr.COVID-19-associated MRSA infective endocarditis and mitral valve perforation: a case report.The Egyptian Heart Journal.19-JUL-2023;75:1-6 | 67 | YR | A | M | Y | null | null | 20230824 | null | HP | US | US |
228583251 | 22858325 | 1 | I | null | 20230731 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017968 | SANDOZ | null | 36 | YR | null | F | Y | null | null | 20230824 | null | MD | US | US |
228583261 | 22858326 | 1 | I | null | 20230814 | 20230824 | 20230824 | EXP | null | US-MSNLABS-2023MSNLIT01419 | MSN LABORATORIES | Dixon A.HEPATITIS B: DON^T FORGET ABOUT ME.Journal of General Internal Medicine.23-JUN-2023;38 (2):S474 | null | null | null | null | Y | null | null | 20230824 | null | HP | US | US |
228583271 | 22858327 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | GB-MHRA-TPP44535237C7379339YC1692021523182 | GB-ESPERIONTHERAPEUTICS-2023GBR00916 | ESPERION THERAPEUTICS | null | 79 | YR | null | F | Y | 77 | KG | 20230824 | null | HP | GB | GB |
228583281 | 22858328 | 1 | I | null | 20230818 | 20230824 | 20230824 | EXP | null | JP-AMGEN-JPNSP2023149109 | AMGEN | null | null | null | null | null | Y | null | null | 20230823 | null | PH | JP | JP |
228583292 | 22858329 | 2 | F | 20230401 | 20230823 | 20230824 | 20230829 | PER | null | US-AMGEN-USASP2023148928 | AMGEN | null | 52 | YR | A | F | Y | null | null | 20230829 | null | HP | US | US |
228583301 | 22858330 | 1 | I | null | 20230815 | 20230824 | 20230824 | EXP | null | US-JNJFOC-20230834060 | JOHNSON AND JOHNSON | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228583311 | 22858331 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118921 | BRISTOL MYERS SQUIBB | null | 64 | YR | A | M | Y | null | null | 20230824 | null | HP | US | US |
228583321 | 22858332 | 1 | I | 20230101 | 20230822 | 20230824 | 20230824 | PER | null | US-ABBVIE-5379414 | ABBVIE | null | null | null | null | null | Y | null | null | 20230824 | null | CN | US | US |
228583331 | 22858333 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | US-NOVITIUMPHARMA-2023USNVP01394 | NOVITIUM PHARMA | Basma Merhi.Obstructive Uropathy due to Bilateral Sliding Hernia in a Renal Transplant Patient with Incidental RCC in Native Kidney.RHODE ISLAND MEDICAL JOURNAL.JUL-2023;106(6):15-19 | 58 | YR | A | M | Y | null | null | 20230824 | null | HP | US | US |
228583341 | 22858334 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023149570 | AMGEN | null | null | null | null | null | Y | null | null | 20230823 | null | PH | US | US |
228583351 | 22858335 | 1 | I | null | 20230728 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017855 | SANDOZ | null | null | null | null | M | Y | 215 | KG | 20230824 | null | HP | US | US |
228583361 | 22858336 | 1 | I | null | 20230728 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017776 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | HP | US | US |
228583371 | 22858337 | 1 | I | null | 20230818 | 20230824 | 20230824 | EXP | null | US-AMAROX PHARMA-HET2023US02452 | HETERO | Chatterjee S, Elsheikh TM, Kirby DF.. Esophageal Plaques in a 68-Year-Old Woman with Systemic Sclerosis.. American Journal of Medicine.. 2023;136(8):e151-152 | 68 | YR | null | F | Y | null | null | 20230824 | null | MD | US | US |
228583381 | 22858338 | 1 | I | null | 20230818 | 20230824 | 20230824 | PER | null | US-ABBVIE-5376001 | ABBVIE | null | null | null | null | null | Y | null | null | 20230824 | null | HP | US | US |
228583391 | 22858339 | 1 | I | 20230601 | 20230822 | 20230824 | 20230824 | PER | null | US-ELI_LILLY_AND_COMPANY-US202308013595 | ELI LILLY AND CO | null | 81 | YR | null | M | Y | null | null | 20230824 | null | CN | US | US |
228583401 | 22858340 | 1 | I | 20230818 | 20230822 | 20230824 | 20230824 | PER | null | US-ELI_LILLY_AND_COMPANY-US202308013991 | ELI LILLY AND CO | null | 52 | YR | null | M | Y | null | null | 20230824 | null | CN | US | US |
228583411 | 22858341 | 1 | I | null | 20230817 | 20230824 | 20230824 | PER | null | US-ELI_LILLY_AND_COMPANY-US202308011154 | ELI LILLY AND CO | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228583421 | 22858342 | 1 | I | 20230501 | 20230815 | 20230824 | 20230824 | EXP | null | BR-002147023-NVSC2023BR128427 | SANDOZ | null | 40 | YR | null | F | Y | 60 | KG | 20230824 | null | CN | BR | BR |
228583431 | 22858343 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-ELI_LILLY_AND_COMPANY-US202308012937 | ELI LILLY AND CO | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228583441 | 22858344 | 1 | I | null | 20230821 | 20230824 | 20230824 | EXP | null | GB-SANDOZ-SDZ2023GB017305 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | CN | GB | GB |
228583451 | 22858345 | 1 | I | 20230817 | 20230818 | 20230824 | 20230824 | EXP | null | JP-009507513-2308JPN002395J | MERCK | null | 85 | YR | null | F | Y | null | null | 20230824 | null | PH | JP | JP |
228583461 | 22858346 | 1 | I | 20230501 | 20230823 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-119062 | BRISTOL MYERS SQUIBB | null | 79 | YR | E | F | Y | 54.43 | KG | 20230824 | null | CN | US | US |
228583471 | 22858347 | 1 | I | null | 20230728 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017882 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | MD | US | US |
228583481 | 22858348 | 1 | I | null | 20230823 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118946 | BRISTOL MYERS SQUIBB | null | 80 | YR | E | F | Y | 54.88 | KG | 20230824 | null | CN | US | US |
228583491 | 22858349 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | PL-NOVITIUMPHARMA-2023PLNVP01396 | NOVITIUM PHARMA | Monika Gorska.Diffuse alveolar hemorrhage in a chronically hemodialyzed patient with progressive necrotic skin lesions as a manifestation of calciphylaxis.Polish Archives of Internal Medicine.23-JUN-2023;133:1-5 | 49 | YR | A | F | Y | null | null | 20230824 | null | HP | PL | PL |
228583503 | 22858350 | 3 | F | 20180101 | 20230913 | 20230824 | 20230918 | PER | null | US-GILEAD-2023-0641120 | GILEAD | null | 52 | YR | A | M | Y | null | null | 20230918 | null | LW | US | US |
228583511 | 22858351 | 1 | I | 20230823 | 20230823 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023149726 | AMGEN | null | null | null | null | F | Y | null | null | 20230823 | null | CN | US | US |
228583521 | 22858352 | 1 | I | 20160630 | 20230815 | 20230824 | 20230824 | EXP | null | CA-002147023-PHHY2016CA092589 | SANDOZ | null | 63 | YR | null | M | Y | 61 | KG | 20230824 | null | CN | CA | CA |
228583541 | 22858354 | 1 | I | null | 20230815 | 20230824 | 20230824 | EXP | null | CA-APOTEX-2023AP012355 | APOTEX | null | 71 | YR | null | M | Y | null | null | 20230824 | null | HP | CA | CA |
228583551 | 22858355 | 1 | I | null | 20230823 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118958 | BRISTOL MYERS SQUIBB | null | 79 | YR | E | M | Y | 93.44 | KG | 20230824 | null | CN | US | US |
228583561 | 22858356 | 1 | I | null | 20230823 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118962 | BRISTOL MYERS SQUIBB | null | 77 | YR | E | M | Y | null | null | 20230824 | null | CN | US | US |
228583571 | 22858357 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | GB-NOVITIUMPHARMA-2023GBNVP01398 | NOVITIUM PHARMA | Grace Yin.Ocular surface squamous neoplasia in a patient following oral steroids for contralateral necrotising scleritis.BMJ Case Reports.15-DEC-2022;15(12):1-4 | null | null | E | M | Y | null | null | 20230824 | null | HP | GB | GB |
228583581 | 22858358 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | US-ABBVIE-5378747 | ABBVIE | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228583591 | 22858359 | 1 | I | 20230118 | 20230818 | 20230824 | 20230824 | EXP | null | DE-SANDOZ-SDZ2023DE017377 | SANDOZ | null | null | null | null | F | Y | 146 | KG | 20230824 | null | HP | DE | DE |
228583601 | 22858360 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | JP-ROCHE-3410072 | ROCHE | null | 8 | DEC | null | F | Y | null | null | 20230824 | null | MD | JP | JP |
228583611 | 22858361 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023148635 | AMGEN | Fadakar K.; Tedeschi T.; Rahmani S. et al.. Short Term Effect of Preoperative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membrane of Proliferative Diabetic Retinopathy. Investigative Ophthalmology and Visual Science. 2023;64 (8):1822 | null | null | null | null | Y | null | null | 20230823 | null | HP | US | US |
228583622 | 22858362 | 2 | F | 20230821 | 20230823 | 20230824 | 20230825 | PER | null | US-AMGEN-USASP2023149220 | AMGEN | null | 78 | YR | E | F | Y | null | null | 20230825 | null | PH | US | US |
228583631 | 22858363 | 1 | I | 20230818 | 20230818 | 20230824 | 20230824 | EXP | null | US-GSK-US2023112745 | GLAXOSMITHKLINE | null | 45 | YR | null | M | Y | null | null | 20230824 | null | PH | US | US |
228583641 | 22858364 | 1 | I | null | 20230813 | 20230824 | 20230824 | EXP | null | GB-GLENMARK PHARMACEUTICALS-2023GMK084339 | GLENMARK | null | null | null | null | null | Y | null | null | 20230824 | null | CN | GB | GB |
228583651 | 22858365 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023148596 | AMGEN | Pandit S.; Wakabayashi T.; Mansour H. et al.. Effects of Intravitreal Faricimab 6.0 mg Injection on Functional and Anatomic Outcomes in Patients with Neovascular Agerelated Macular Degeneration. Investigative Ophthalmology and Visual Science. 2023;64 (8):2235 | null | null | null | null | Y | null | null | 20230823 | null | HP | US | US |
228583661 | 22858366 | 1 | I | null | 20230727 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017912 | SANDOZ | null | null | null | null | M | Y | 133.3 | KG | 20230824 | null | MD | US | US |
228583681 | 22858368 | 1 | I | null | 20230821 | 20230824 | 20230824 | EXP | null | US-JAZZ PHARMACEUTICALS-2023-US-017811 | JAZZ | null | null | null | null | M | Y | null | null | 20230824 | null | CN | US | US |
228583692 | 22858369 | 2 | F | null | 20230915 | 20230824 | 20230918 | EXP | null | FR-BRISTOL-MYERS SQUIBB COMPANY-2023-103878 | BRISTOL MYERS SQUIBB | null | 46 | YR | A | F | Y | null | null | 20230918 | null | PH | FR | FR |
228583701 | 22858370 | 1 | I | null | 20230818 | 20230824 | 20230824 | EXP | null | GB-CELLTRION INC.-2023GB016591 | CELLTRION | null | null | null | null | null | Y | null | null | 20230824 | null | HP | GB | GB |
228583711 | 22858371 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | US-NOVITIUMPHARMA-2023USNVP01399 | NOVITIUM PHARMA | Paulina S. Marell.Primary hepatic Epstein-Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report.Journal of Medical Case Reports volume.02-MAY-2023;17:1-5 | 46 | YR | A | F | Y | null | null | 20230824 | null | HP | US | US |
228583722 | 22858372 | 2 | F | null | 20230728 | 20230824 | 20230825 | PER | null | NVSC2023US183948 | NOVARTIS | null | null | null | null | M | Y | null | null | 20230825 | null | MD | US | US |
228583731 | 22858373 | 1 | I | 20230811 | 20230815 | 20230824 | 20230824 | EXP | null | US-PADAGIS-2023PAD01160 | PADAGIS | null | null | null | null | null | Y | null | null | 20230824 | null | CN | US | US |
228583741 | 22858374 | 1 | I | null | 20230809 | 20230824 | 20230824 | PER | null | US-EPICPHARMA-US-2023EPCSPO01309 | EPIC PHARM | null | 81 | YR | E | F | Y | null | null | 20230824 | null | CN | US | US |
228583751 | 22858375 | 1 | I | null | 20230728 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017842 | SANDOZ | null | null | null | null | F | Y | 79.55 | KG | 20230824 | null | MD | US | US |
228583761 | 22858376 | 1 | I | null | 20230819 | 20230824 | 20230824 | EXP | null | GB-SANDOZ-SDZ2023GB017400 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | CN | GB | GB |
228583771 | 22858377 | 1 | I | null | 20230728 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017456 | SANDOZ | null | null | null | null | M | Y | 73.18 | KG | 20230824 | null | MD | US | US |
228583781 | 22858378 | 1 | I | 20230815 | 20230815 | 20230824 | 20230824 | EXP | null | US-PADAGIS-2023PAD01157 | PADAGIS | null | null | null | null | null | Y | null | null | 20230824 | null | CN | US | US |
228583791 | 22858379 | 1 | I | 20230822 | 20230823 | 20230824 | 20230824 | EXP | null | RU-SANDOZ-SDZ2023RU017755 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | MD | RU | RU |
228583801 | 22858380 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | US-NOVITIUMPHARMA-2023USNVP01404 | NOVITIUM PHARMA | Abdullahi Sulaiman.DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AS A CAUSE OF IGA NEPHROPATHY.American Journal of Kidney Diseases.01-APR-2023;81(4):S9-S10 | 71 | YR | E | F | Y | null | null | 20230824 | null | HP | US | US |
228583811 | 22858381 | 1 | I | 20230801 | 20230801 | 20230824 | 20230824 | 30DAY | null | AU-JNJFOC-20230801652 | JOHNSON AND JOHNSON | null | null | null | null | F | Y | null | null | 20230824 | null | CN | AU | AU |
228583821 | 22858382 | 1 | I | null | 20230818 | 20230824 | 20230824 | PER | null | US-JNJFOC-20230845915 | JOHNSON AND JOHNSON | null | null | null | null | M | Y | null | null | 20230824 | null | CN | US | US |
228583831 | 22858383 | 1 | I | null | 20230817 | 20230824 | 20230824 | PER | null | US-SA-2023SA254247 | SANOFI AVENTIS | null | 57 | YR | A | F | Y | null | null | 20230824 | null | HP | US | US |
228583842 | 22858384 | 2 | F | 20230801 | 20230912 | 20230824 | 20230922 | PER | null | US-SA-2023SA253105 | SANOFI AVENTIS | null | 11 | YR | C | M | Y | null | null | 20230922 | null | MD | US | US |
228583851 | 22858385 | 1 | I | null | 20230607 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017564 | SANDOZ | null | null | null | null | F | Y | 63.492 | KG | 20230824 | null | HP | US | US |
228583862 | 22858386 | 2 | F | 20230816 | 20230817 | 20230824 | 20230829 | PER | null | US-SA-2023SA254256 | SANOFI AVENTIS | null | 12 | YR | T | F | Y | 32.698 | KG | 20230829 | null | MD | US | US |
228583871 | 22858387 | 1 | I | null | 20230823 | 20230824 | 20230824 | EXP | null | GB-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-246761 | BOEHRINGER INGELHEIM | null | null | null | null | M | Y | null | null | 20230824 | null | CN | GB | GB |
228583881 | 22858388 | 1 | I | null | 20230821 | 20230824 | 20230824 | EXP | null | GB-ABBVIE-5378875 | ABBVIE | null | 55 | YR | null | F | Y | null | null | 20230824 | null | CN | GB | GB |
228583891 | 22858389 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-AstraZeneca-2023A191441 | ASTRAZENECA | null | null | null | null | null | Y | null | null | 20230824 | null | CN | US | null |
228583901 | 22858390 | 1 | I | null | 20230817 | 20230824 | 20230824 | EXP | null | US-AstraZeneca-2023A188370 | ASTRAZENECA | null | null | null | null | null | Y | null | null | 20230824 | null | CN | US | null |
228583911 | 22858391 | 1 | I | null | 20230818 | 20230824 | 20230824 | EXP | null | ET-NOVITIUMPHARMA-2023ETNVP01401 | NOVITIUM PHARMA | Yihienew M. Bezabih.Hypocalcemic tetany associated with simultaneous administration of cimetidine and nifedipine: a case report.Journal of Medical Case Reports.28-JUL-2023;17(1):1-4 | 46 | YR | A | F | Y | null | null | 20230824 | null | HP | ET | ET |
228583921 | 22858392 | 1 | I | 20230101 | 20230810 | 20230824 | 20230824 | PER | null | US-EPICPHARMA-US-2023EPCSPO01311 | EPIC PHARM | null | 70 | YR | E | F | Y | 150 | KG | 20230824 | null | CN | US | US |
228583931 | 22858393 | 1 | I | null | 20230811 | 20230824 | 20230824 | EXP | null | US-PADAGIS-2023PAD01165 | PADAGIS | Kalra K, Whittington CP, Sevey W, Hunt E, Metz JB. Delusions of parasitosis and delusions of parasitosis by proxy in a mother and her children. Pediatric Dermatology. 2023;40(3):544-546 | null | null | null | null | Y | null | null | 20230824 | null | HP | US | US |
228583951 | 22858395 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118849 | BRISTOL MYERS SQUIBB | null | 57 | YR | A | F | Y | null | null | 20230824 | null | HP | US | US |
228583971 | 22858397 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023149291 | AMGEN | null | null | null | null | null | Y | null | null | 20230823 | null | MD | US | US |
228583981 | 22858398 | 1 | I | 20230801 | 20230815 | 20230824 | 20230824 | EXP | null | US-PADAGIS-2023PAD01161 | PADAGIS | null | null | null | null | null | Y | null | null | 20230824 | null | PH | US | US |
228583991 | 22858399 | 1 | I | null | 20230606 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017505 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | HP | US | US |
228584001 | 22858400 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | JP-STL-000132 | Stallion Laboratories | Saito S, Iijima M, Ikeguchi R, Ishizuka K, Kitagawa K. Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis. Cureus. 2023 Jul 10;15(7):e41666. doi: 10.7759/cureus.41666. | 60 | YR | null | M | Y | null | null | 20230823 | null | HP | JP | JP |
228584011 | 22858401 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | JP-STL-000131 | Stallion Laboratories | Saito S, Iijima M, Ikeguchi R, Ishizuka K, Kitagawa K. Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis. Cureus. 2023 Jul 10;15(7):e41666. doi: 10.7759/cureus.41666. | 34 | YR | null | M | Y | null | null | 20230823 | null | HP | JP | JP |
228584022 | 22858402 | 2 | F | 20230701 | 20230822 | 20230824 | 20230830 | PER | null | US-AMGEN-USASP2023148774 | AMGEN | null | 74 | YR | null | M | Y | null | null | 20230829 | null | HP | US | US |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.